NMT1
Basic information
Region (hg38): 17:44957992-45109016
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NMT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 36 | 36 | ||||
Total | 0 | 0 | 49 | 0 | 0 |
Variants in NMT1
This is a list of pathogenic ClinVar variants found in the NMT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-44960201-A-G | not specified | Uncertain significance (May 23, 2023) | ||
17-44960289-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
17-44960310-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
17-44967634-G-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
17-44967669-A-C | not specified | Uncertain significance (Aug 13, 2021) | ||
17-44967700-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
17-44967705-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
17-44967711-G-A | not specified | Uncertain significance (May 31, 2023) | ||
17-44967723-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
17-44967733-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
17-44967793-C-A | not specified | Uncertain significance (Jul 06, 2021) | ||
17-44967823-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
17-44967853-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
17-44967870-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
17-44967912-G-A | not specified | Uncertain significance (May 26, 2024) | ||
17-44967925-C-T | not specified | Uncertain significance (Feb 13, 2023) | ||
17-44967996-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
17-45024488-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
17-45024489-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
17-45024518-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
17-45024537-G-A | not specified | Uncertain significance (Nov 10, 2023) | ||
17-45024552-G-A | not specified | Uncertain significance (May 13, 2024) | ||
17-45024611-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
17-45024674-C-T | not specified | Uncertain significance (Jul 16, 2021) | ||
17-45024690-G-A | not specified | Uncertain significance (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NMT1 | protein_coding | protein_coding | ENST00000592782 | 12 | 57407 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.996 | 0.00450 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.48 | 173 | 292 | 0.592 | 0.0000165 | 3297 |
Missense in Polyphen | 19 | 90.678 | 0.20953 | 1005 | ||
Synonymous | 0.352 | 107 | 112 | 0.958 | 0.00000645 | 928 |
Loss of Function | 4.49 | 3 | 29.2 | 0.103 | 0.00000175 | 304 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:9353336, ECO:0000269|PubMed:9506952}.;
- Pathway
- Signaling by GPCR;Disease;Signal Transduction;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;Intrinsic Pathway for Apoptosis;Infectious disease;Apoptosis;Programmed Cell Death;Activation, myristolyation of BID and translocation to mitochondria;G alpha (i) signalling events;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.0670
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.31
Haploinsufficiency Scores
- pHI
- 0.603
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nmt1
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- in utero embryonic development;N-terminal protein myristoylation;N-terminal peptidyl-glycine N-myristoylation;regulation of rhodopsin mediated signaling pathway;cellular ketone metabolic process;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
- Cellular component
- cytoplasm;mitochondrion;cytosol;plasma membrane;extrinsic component of membrane
- Molecular function
- glycylpeptide N-tetradecanoyltransferase activity;myristoyltransferase activity